Clinical Trial Update: Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating different schedules of pegylated interferon and ribavirin for chronic hepatitis C in real-world practice. The study has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Liver Disease

Drugs mentioned

• PegIntron (pegylated interferon alfa-2b)
• Pegasys (pegylated interferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: Azienda Ospedaliera di Padova | Conditions: Hepatitis C Virus, Chronic Liver Disease | Phase 4 | Status: COMPLETED